Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Sell Order

<< Previous

Bullboard Posts

Next >>

Comment by consultant99on Apr 17, 2023 11:39pm

158 Views

Post# 35399745

RE:RE:Sell Order

Perhaps they have a brokered deal in the works. Perhaps that deal will be announced after the FDA responds to the BTD application which as all of us believe will be approved.

Honestly I can't think of any legitimate reason for not publishing a 3 month update - unless they had a deal cooking in the kitchen.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec